ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib

Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population

Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs

Insights into germline genetic screening of breast cancer patients

Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC

Study shows association between tumour KIM-1 gene (HAVCR1) expression and immune infiltrates in RCC

Determinants of cancer disparities - Data driven insights from South East Asia

Bladder cancer updates from the second half of 2024

Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions

Relationship between governance and cervical cancer control

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer

Advancements in minimal residual disease detection in myeloma